Skip to main content

GE HealthCare Technologies Inc. company profile

  • GEHC · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$83.02+1.44%Close 13 Nov 2026 · Market value $37.71B

About GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. is a healthcare solutions provider that sells medical devices, consumable products, service capabilities, and AI-enabled cloud and software solutions. It operates four segments: Imaging, which covers molecular imaging, computed tomography, magnetic resonance, women's health, and X-ray; Advanced Visualization Solutions, which includes ultrasound and procedural guidance systems; Patient Care Solutions, which offers patient monitoring, diagnostic cardiology, maternal infant care, and anesthesia products; and Pharmaceutical Diagnostics, which supplies contrast media and radiopharmaceutical imaging agents. Its customers include hospitals, health systems, and researchers across public, private, academic, and government institutions. The company serves customers in over 160 countries and manufactures products at 44 facilities across 17 countries.

A summary of the business section of the company's latest annual report, filed 4 Feb 2026.

Company facts

TickerGEHC · Nasdaq
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1932393
Latest annual report10-K, filed 4 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Peter J. ArduiniPresident and CEO · Director510K · < 1%Shares withheld for tax, 3 Sep 2026
H. Lawrence Culp, Jr.Director411K · < 1%Grant or award, 7 May 2026
Taha Kass-HoutChief Technology Officer147K · < 1%Shares withheld for tax, 3 Sep 2026
Frank R. JimenezGC & Corporate Secretary146K · < 1%Shares withheld for tax, 3 Sep 2026
James SaccaroChief Financial Officer137K · < 1%Open-market purchase, 1 May 2026
William J. StrombergDirector14.3K · < 1%Grant or award, 7 May 2026
Rodney F. HochmanDirector13.6K · < 1%Open-market purchase, 12 May 2026
Anne T. MaddenDirector13.6K · < 1%Grant or award, 7 May 2026
Risa Lavizzo-MoureyDirector10.2K · < 1%Grant or award, 28 May 2025
Catherine LesjakDirector9.1K · < 1%Grant or award, 7 May 2026
Tomislav MihaljevicDirector9.1K · < 1%Grant or award, 28 May 2025
Phoebe L. YangDirector3.1K · < 1%Open-market purchase, 8 May 2026
Jeannette BankesCEO, Patient Care Solutions0 · 0%Shares withheld for tax, 1 Sep 2026
Kevin A. LoboDirector0 · 0%Open-market purchase, 22 May 2026
Grogan William KChief Financial Officer—Grant or award, 14 Sep 2026
Estrampes CatherineChief Commer. & Growth Officer—Shares withheld for tax, 3 Sep 2026
Rackliffe PhilipCEO, AIS—Shares withheld for tax, 3 Sep 2026
Newcomb George A.Chief Accounting Officer—Shares withheld for tax, 3 Sep 2026
O'Neill Kevin MichaelCEO, PDx—Shares withheld for tax, 3 Sep 2026
Holton Adam YChief People Officer—Shares withheld for tax, 3 Sep 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

GEHC in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.